Physician profile
Andre M Ishak
NPI 1639135445
$10,788.32
in general payments reported to CMS, 2019-2025
10 companies · $196 in 2025
The $196 reported for 2025 was less than what a typical Surgery of The Hand (Surgery) provider received nationally (typical 2025 total: $285).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $312 · 2020: $102 · 2022: $9,942 · 2023: $13.47 · 2024: $222 · 2025: $196.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $432.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $432.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medartis INC. | $10,022.41 | 2019-2023 | Aptus |
| Endo Pharmaceuticals INC. | $250.33 | 2019-2024 | Xiaflex |
| Skeletal Dynamics INC | $151.47 | 2024 | Geminus, Implate, Align |
| Endo USA, INC. | $117.87 | 2024-2025 | Xiaflex |
| Depuy Synthes Sales INC. | $78.77 | 2019 | |
| Stryker Corporation | $62.15 | 2025 | Pangea |
| Vertex Pharmaceuticals Incorporated | $34.79 | 2025 | |
| Bioventus LLC | $31.88 | 2024 | Durolane |
| Horizon Therapeutics Plc | $27.26 | 2019 | |
| Team_makena_llc | $11.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andre Ishak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.